These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30755496)

  • 1. Accuracy of renal tumour biopsy for the diagnosis and subtyping of papillary renal cell carcinoma: analysis of paired biopsy and nephrectomy specimens with focus on discordant cases.
    Prendeville S; Richard PO; Jewett MAS; Kachura JR; Sweet JM; van der Kwast TH; Cheung CC; Finelli A; Evans AJ
    J Clin Pathol; 2019 May; 72(5):363-367. PubMed ID: 30755496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accuracy of renal tumor biopsy: analysis from a national prospective study.
    Bernhard JC; Bigot P; Pignot G; Baumert H; Zini L; Lang H; Crepel M; Monod P; Salomon L; Bellec L; Roupret M; Schneider M; Xylinas E; Paparel P; Bruyere F; Berger J; Ansieau JP; Gimel P; Salome F; Castagnola C; Pfister C; Legraverend JM; Timsit MO; Le Pellec L; Auberget JL; Rolland E; Mallet R; Mejean A; Patard JJ;
    World J Urol; 2015 Aug; 33(8):1205-11. PubMed ID: 25373933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance between renal tumour biopsy and robotic-assisted partial and radical nephrectomy histology: a 10-year experience.
    Kinnear N; Kucheria A; Ogbechie C; Adam S; Haidar O; Cotter Fonseca P; Brodie A; Pullar B; Adshead J
    J Robot Surg; 2024 Jan; 18(1):45. PubMed ID: 38240940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does renal tumor biopsies for small renal carcinoma increase the risk of upstaging on final surgery pathology report and the risk of recurrence?
    Asselin C; Finelli A; Breau RH; Mallick R; Kapoor A; Rendon RA; Tanguay S; Pouliot F; Fairey A; Lavallée LT; Bladou F; Kawakami J; So AI; Richard PO
    Urol Oncol; 2020 Oct; 38(10):798.e9-798.e16. PubMed ID: 32693974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery.
    Bigot P; Bernhard JC; Gill IS; Vuong NS; Verhoest G; Flamand V; Reix B; Suer E; Gökce I; Beauval JB; Nouhaud FX; Eto M; Baco E; Matsugasumi T; Chowaniec Y; Rigaud J; Lenormand C; Pfister C; Hetet JF; Ploussard G; Roupret M; Léon P; Bakri AE; Larré S; Tillou X; Doerfler A; Descazeaud A; Koutlidis N; Schneider A; Sebe P; Ingels A; Azzouzi AR; Soulié M; Méjean A; Bensalah K; Patard JJ;
    World J Urol; 2016 Mar; 34(3):347-52. PubMed ID: 26149352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis.
    Saleeb RM; Brimo F; Farag M; Rompré-Brodeur A; Rotondo F; Beharry V; Wala S; Plant P; Downes MR; Pace K; Evans A; Bjarnason G; Bartlett JMS; Yousef GM
    Am J Surg Pathol; 2017 Dec; 41(12):1618-1629. PubMed ID: 28984673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Subclassification of Papillary Renal Cell Carcinoma: Comparison of Clinicopathologic Parameters and Oncologic Outcomes Between Papillary Histologic Subtypes 1 and 2 Using the Korean Renal Cell Carcinoma Database.
    Ha YS; Chung JW; Choi SH; Lee JN; Kim HT; Kim TH; Chung SK; Byun SS; Hwang EC; Kang SH; Hong SH; Chung J; Kwak C; Kim YJ; Kwon TG;
    Clin Genitourin Cancer; 2017 Apr; 15(2):e181-e186. PubMed ID: 27595560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
    Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
    Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
    Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
    Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
    Abel EJ; Carrasco A; Culp SH; Matin SF; Tamboli P; Tannir NM; Wood CG
    BJU Int; 2012 Dec; 110(11):1742-6. PubMed ID: 22503066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typical signs of oncocytic papillary renal cell carcinoma in everyday clinical praxis.
    Urge T; Hes O; Ferda J; Chudácek Z; Eret V; Michal M; Brunelli M; Martignoni G; Hora M
    World J Urol; 2010 Aug; 28(4):513-7. PubMed ID: 20454896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histologic subtyping and clinicopathologic features of papillary renal cell carcinoma].
    Zhang Y; He H
    Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):761-6. PubMed ID: 26888384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy.
    Marconi L; Dabestani S; Lam TB; Hofmann F; Stewart F; Norrie J; Bex A; Bensalah K; Canfield SE; Hora M; Kuczyk MA; Merseburger AS; Mulders PFA; Powles T; Staehler M; Ljungberg B; Volpe A
    Eur Urol; 2016 Apr; 69(4):660-673. PubMed ID: 26323946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
    Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
    BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomorphologic comparison of type 1 and type 2 papillary renal cell carcinoma: A retrospective analysis of 28 cases.
    Magers MJ; Perrino CM; Cramer HM; Wu HH
    Cancer Cytopathol; 2019 Jun; 127(6):370-376. PubMed ID: 31091016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, reliability and accuracy of small renal tumour biopsies: results from a multi-institution registry.
    Richard PO; Jewett MA; Tanguay S; Saarela O; Liu ZA; Pouliot F; Kapoor A; Rendon R; Finelli A
    BJU Int; 2017 Apr; 119(4):543-549. PubMed ID: 27528446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year Experience.
    Richard PO; Jewett MA; Bhatt JR; Kachura JR; Evans AJ; Zlotta AR; Hermanns T; Juvet T; Finelli A
    Eur Urol; 2015 Dec; 68(6):1007-13. PubMed ID: 25900781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.